Osmofundin N (Mannitol)

Osmofundin N is an osmotic diuretic that acts on fluid balance pathways in the body.

• Cerebral edema: helps reduce intracranial pressure and cerebral swelling.
• Acute kidney injury: facilitates renal excretion of water and electrolytes.
• Glaucoma surgery: used intra‑operatively to lower intra‑ocular pressure.
• Drug intoxication: aids in renal clearance of certain toxins.
• Hyperkalemia management: supports removal of excess potassium through increased urine output.

• Mannitol creates an osmotic gradient across the glomerular membrane, drawing water from intracellular and interstitial spaces into the vascular compartment. This increased plasma volume promotes renal filtration, while its high osmolarity in the central nervous system reduces cerebral edema by drawing fluid out of brain tissue.

Adverse reactions to mannitol are reported across a range of severity.

Common Side Effects

• Headache: mild to moderate discomfort.
• Nausea: occasional upset stomach.
• Electrolyte imbalance: mild changes in sodium or potassium levels.
• Transient hypertension: short‑term rise in blood pressure.
• Volume overload: signs of fluid retention.

Serious or Rare Side Effects

• Acute renal failure: sudden loss of kidney function.
• Pulmonary edema: fluid accumulation in the lungs.
• Severe hyponatremia or hypernatremia: dangerous shifts in sodium concentration.
• Anaphylactoid reaction: rare allergic‑type response.
• Cardiac arrhythmia: abnormal heart rhythm linked to electrolyte shifts.

When using Osmofundin N, clinicians should observe several safety measures.

• Renal function monitoring: assess creatinine and urine output regularly.
• Cardiovascular status: watch for signs of fluid overload or hypertension.
• Electrolyte surveillance: check serum sodium and potassium frequently.
• Infusion rate control: administer slowly to avoid rapid plasma osmolar shifts.
• Contraindications review: avoid in patients with severe pulmonary edema or active intracranial hemorrhage.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Mannitol may interact with several medicines, requiring careful management.

Major Interactions (Avoid)

• Loop diuretics: combined use can precipitate severe electrolyte disturbances.
• Nephrotoxic antibiotics: increased risk of acute kidney injury.
• Vasopressors: may blunt intended blood‑pressure effects.

Moderate Interactions (Monitor Closely)

• Antihypertensives: may enhance hypotensive response.
• Lithium: altered renal clearance can raise lithium levels.
• Insulin: rapid shifts in plasma volume may affect glucose control.